此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

BoStOn Scientific Rhythm MManagement Registry (苏格拉底) (SOCRATES)

2026年10月30日 更新者:Boston Scientific Corporation

波士顿科学节律管理登记处

SOCRATES is part of Boston Scientific's (BSC) Post-market surveillance system. The implementation of such systems is mandatory per local regulations such as the Regulation '(EU) 2017/745 of the European Parliament and of the Council of 5 April 2017 on medical devices' or short Medical Device Regulation (MDR). The SOCRATES design is therefore based on the BSC's commitment as well as external regulatory requirements to proactively and systematically gather, record and analyze relevant data on the quality, performance and safety of devices throughout their entire lifetime.

研究概览

详细说明

SOCRATES is a non-randomized, multisite, single-arm, open-label, global post-market observational data collection per standard of care. While generally of prospective design, a limited retrospective element is allowed for the inclusion of patients for a short period of 10 days after their index procedure.

SOCRATES intends to enroll a number of subjects that will support the analysis of all the individual Post Market Clinical Follow-Up (PMCF) Plans. An average of approximately 100 subjects per year and site on a continuous basis is expected but may vary depending on the needs of individual PMCF Plans. As long as SOCRATES is active, there is no upper limit to the total number of subjects that may be enrolled, and enrollment will be driven by the need to support sample sizes of individual PMCF plans for given products/product groupings supported by SOCRATES.

SOCRATES is designed to be a continuous effort after the data collection commences without a predefined closure timepoint. Data collection and enrollment may be stopped, restarted or finalized per Sponsor discretion.

The expected duration of SOCRATES participation for a subject is dependent on

  • the specific lifetime of the device (e.g. the battery usage for pulse generators or continued active use of leads for CRM devices) or
  • the necessary timeframe to adequately assess safety and performance of the device based on the residual risk assessed for each device in the associated PMCF plan. Timeframes might e.g. spread from 7 days to one year post procedure for EP. The maximum duration per enrolled subject will consequently vary.

For BSC implantable devices subjects are intended to be followed for the entire time of being implanted with a BSC device to allow data collection over the lifetime of the device(s) as required by applicable regulations. A maximum duration per enrolled subject is not defined, unless locally required. In case a local maximum duration is enforced subjects may be consented again and re-enrolled for continued participation if they are still in scope for SOCRATES. Sites shall ensure continuous data collection without any gaps in case a re-enrollment becomes applicable. Data sets for re-enrolled subjects will be handled as if the subject was continuously enrolled. This process will ensure to meet the requirement of MDR for device manufacturers to collect data over the lifetime of the devices.

研究类型

观察性的

注册 (估计的)

12500

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习联系方式

研究联系人备份

学习地点

      • Ramat Gan、以色列、52621
        • 招聘中
        • Sheba Medical Center
        • 接触:
          • Roy Beinart, MD
      • Tel Aviv、以色列、6423906
        • 招聘中
        • Tel Aviv Sourasky Medical Center
        • 接触:
          • Raphael Rosso, Professor
      • Tel Aviv、以色列、62431
        • 招聘中
        • Tel Aviv Sourask Medical Center
        • 接触:
          • Raphael Rosso, Professor
    • Quebec
      • Québec、Quebec、加拿大、G1V 4G5
        • 招聘中
        • Institut Universitaire de Cardiologie et de Pneumologie de Quebec
        • 接触:
          • Jean-Francois Sarrazin, MD
      • Athens、希腊、17674
        • 招聘中
        • Onassis Cardiac Surgery Center
        • 接触:
          • Michael Ephremidis, MD
      • Athens、希腊、11527
        • 完全的
        • General Hospital of Athens "G. Gennimatas"
      • Berlin、德国、12687
        • 招聘中
        • Unfallkrankenhaus Berlin Marzahn
        • 接触:
          • Corinna Lenz, MD
      • Bochum、德国、44791
        • 完全的
        • Augusta Kranken Anstalt GmbH
      • Modena、意大利、41124
        • 招聘中
        • Policlinico di Modena
        • 接触:
          • Giuseppe Boriani, Prof.
      • Roma、意大利、00168
        • 招聘中
        • Policlinico Universitario Agostino Gemelli
        • 接触:
          • Gemma Pelargonio, MD
      • Roma、意大利、00169
        • 招聘中
        • Policlinico Casilino
        • 接触:
          • Leonardo Calò, MD
      • Roma、意大利、00186
        • 招聘中
        • Ospedale S.G. Calibita Fatebenefratelli - Isola Tiberina
        • 接触:
          • Stefano Bianchi, MD
      • Jette、比利时、1090
        • 招聘中
        • Universitair Ziekenhuis Brussel
        • 接触:
          • Carlo de Asmundis, Prof.
      • Yvoir、比利时、5530
        • 招聘中
        • CHU UCL Namur - Site Godinne
        • 接触:
          • Dominique Blommaert, Prof.
      • Brest、法国、29200
        • 招聘中
        • CHRU de Brest, Hôpital de la Cavale Blanche
        • 接触:
          • Jacques Mansourati, Prof.
      • Clermont-Ferrand、法国、63000
        • 招聘中
        • CHRU de Clermont-Ferrand
        • 接触:
          • Romain Eschalier, MD
      • Lomme、法国、59462
        • 招聘中
        • Hopital Saint Philibert
        • 接触:
          • Aymeric Menet, MD
      • Pau、法国
        • 招聘中
        • CHG de Pau
        • 接触:
          • Hugues Bader, MD
      • Saint-Etienne、法国、42055
        • 招聘中
        • CHU de Saint-Etienne
        • 接触:
          • Antoine Da Costa, Prof.
      • Dublin、爱尔兰、D07 WKW8
        • 招聘中
        • Mater Private Hospital
        • 接触:
          • Gabor Szeplaki, Prof.
      • London、英国、EC1A 7BE
        • 招聘中
        • St. Bartholomew's Hospital
        • 接触:
          • Ross Hunter, Prof.
      • Manchester、英国、M13 9WL
        • 招聘中
        • Manchester Heart Center
        • 接触:
          • Charles Pearman, MD
      • Madrid、西班牙、28040
        • 招聘中
        • Hospital Clinico San Carlos
        • 接触:
          • Nicasio Pérez Castellano, MD
      • San Cristóbal de La Laguna、西班牙、38320
        • 招聘中
        • Hospital Universitario de Canarias
        • 接触:
          • Francisco Bosa Ojeda, MD
      • Santa Cruz de Tenerife、西班牙、38010
        • 招聘中
        • Hospital Nuestra Señora de La Candelaria
        • 接触:
          • Luis A. Acosta, MD
      • Zaragoza、西班牙、50009
        • 招聘中
        • Hospital Universitario Miguel Servet
        • 接触:
          • Antonio Asso Abadía, MD

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

  • 孩子
  • 成人
  • 年长者

接受健康志愿者

不

有资格学习的性别

全部

取样方法

非概率样本

研究人群

The subjects will be recruited from the general patient population of the participating centers who are

  • receiving diagnosis or treatment using a BSC product in scope of SOCRATES and
  • fulfilling all inclusion criteria and none of the exclusion criteria.

描述

Inclusion Criteria:

  1. Subject is willing and capable of providing informed consent and/or to give approval to collect/store/process personal health information by the sponsor or such consent/approval is provided by a legally designated representative, if required by local law or regulation.
  2. Subject is (one criterion must be fulfilled) a. prospectively scheduled for a procedure involving i. use of a BSC EP Ablation product or BSC Capital Equipment product or ii. a BSC CRM product implant or b. retrospectively enrolled no more than 10 days after the index procedure and all data necessary for appropriate reporting of all past visits is available and complete including i. the procedure where being diagnosed or treated with at least 3 separate BSC EP Ablation products/components or BSC Capital Equipment products/components or ii. the BSC CRM product implant.

Exclusion Criteria:

  1. Subject is foreseen not to be followed at the enrolling center for at least 1 year after an implant procedure (CRM) or at least 1 month (EP).
  2. Subject is receiving diagnosis or therapy by means of any product, that is not approved for commercial use at the time of implant/procedure.

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

  • 观测模型:COHORT
  • 时间观点:OTHER

队列和干预

团体/队列
干预/治疗
BSC Product Use

Subject fulfilling one of the following conditions:

a. prospectively scheduled for a procedure involving i. use of a BSC EP Ablation product or BSC Capital Equipment product or ii. a BSC CRM product implant or b. retrospectively enrolled no more than 10 days after the index procedure and and all data necessary for appropriate reporting of all past visits is available and complete including i. the procedure where being diagnosed or treated with at least 3 separate BSC EP Ablation products/components or BSC Capital Equipment products/components or ii.the BSC CRM product implant.

In the scope of the CRM procedure and subsequent follow-up, the registry will provide information on the use of the Boston Scientific CRM products/components and combination of those products/components with competitor product(s) per hospital's standard of care.

In the scope of the EP procedure and subsequent follow-up, the registry will provide information on the use of the Boston Scientific Electrophysiology products/components and capital equipment products and combination of those products/components with competitor product(s) per hospital's standard of care.

研究衡量的是什么?

主要结果指标

结果测量
措施说明
大体时间
System-related complication free rate
大体时间:From Cardiac Rhythm Management (CRM) device implant on day 0 through follow-up up to 10 years; from electrophysiological (EP) procedure on day 0 through follow-up from 30 days up to 1 year

Freedom from complications related to system

From Cardiac Rhythm Management (CRM) device implant on day 0 through follow-up up to 10 years; from electrophysiological (EP) procedure on day 0 through follow-up from 30 days up to 1 year
Rate of product related performance deficiencies per product or product group
大体时间:CRM implant on day 0; EP procedure on day 0

Performance of product/product group at implant/procedure

CRM implant on day 0; EP procedure on day 0
Rate of product related performance deficiencies per product or product group
大体时间:CRM implant on day 0 through the implanted duration up to 10 years

Performance of product/product group through the implanted duration

CRM implant on day 0 through the implanted duration up to 10 years

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

调查人员

  • 研究主任:Eszter Pais, MD、Boston Scientific Corporation

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始 (实际的)

2021年3月31日

初级完成 (估计的)

2030年12月31日

研究完成 (估计的)

2030年12月31日

研究注册日期

首次提交

2021年3月18日

首先提交符合 QC 标准的

2021年3月26日

首次发布 (实际的)

2021年4月1日

研究记录更新

最后更新发布 (实际的)

2026年11月2日

上次提交的符合 QC 标准的更新

2026年10月30日

最后验证

2026年10月1日

更多信息

与本研究相关的术语

计划个人参与者数据 (IPD)

计划共享个人参与者数据 (IPD)?

不

药物和器械信息、研究文件

研究美国 FDA 监管的药品

不

研究美国 FDA 监管的设备产品

不

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

订阅